Roundup: South Korea’s first DTx for insomnia receives regulatory approval and additional roundups

South Korea got rid of the first local insomnia DTx

The Ministry of Food and Drug Safety of South Korea has approved a digital therapeutic device for the treatment of insomnia for the first time on the market. reportage.

mobile medical device as software called Somzz by Aimmed offers a CBT program that helps increase sleep duration.

India approves CardiacSense health monitoring smart watch

Xplore Health, a medical technology company in India, has received approval from the Indian regulatory authority for a wearable health monitoring device it wears.

The company is a distributor of medical smartwatches by Israeli medical equipment developer CardiacSense.

Bace on news report, smart watch provides continuous monitoring of vital signs and can request ECG readings when the user’s heart rate fluctuates. It also allows such health data to be instantly transmitted to their healthcare team for further evaluation.

Approval precedes commercial launch CardiacSensewhich has also been approved by the US Food and Drug Administration and is available in over 40 countries worldwide.

Mindray launches wireless ultrasound system

Chinese medical device manufacturer Mindray has unveiled a new wireless handheld ultrasound system that delivers high quality images with less power consumption.

The press release notes that the device, called TE Air, is capable of doing this because it is based on the Mindray eWave platform and second-generation Single Crystal technology.

It is also said to be easy to use in a variety of medical settings, and has features such as exam presets and a range of imaging modes.

The waterproof and dustproof device is also compatible with the mobile app for Android and iOS devices, allowing one-handed operation anywhere. It can also integrate with HIS and can collect and share de-identified data.